Oaktree Acquisition III Life Sciences Revenue 2025-2024 | OACC

Oaktree Acquisition III Life Sciences revenue from 2025 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Oaktree Acquisition III Life Sciences Annual Revenue
(Millions of US $)
Oaktree Acquisition III Life Sciences Quarterly Revenue
(Millions of US $)
2024-09-30
Sector Industry Market Cap Revenue
$0.233B $0.000B
Oaktree Acquisition Corp. III Life Sciences is a blank check company. It formed for the purpose of entering into a combination with one or more businesses or entities. Oaktree Acquisition Corp. III is based in LOS ANGELES.
Stock Name Country Market Cap PE Ratio
Flowco Holdings (FLOC) United States $1.659B 0.00
Antalpha Platform Holding (ANTA) $0.271B 0.00
Aduro Clean Technologies (ADUR) Canada $0.246B 0.00
Gesher Acquisition II (GSHR) $0.150B 0.00
Range Capital Acquisition (RANG) United States $0.142B 0.00
Tavia Acquisition (TAVI) $0.141B 0.00
YSX Tech (YSXT) China $0.115B 0.00
CO2 Energy Transition (NOEM) United States $0.096B 0.00
Leishen Energy Holding (LSE) China $0.086B 0.00
YHN Acquisition I (YHNA) $0.083B 0.00
Youxin Technology (YAAS) China $0.042B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.024B 0.00
Uni-Fuels Holdings (UFG) $0.019B 0.00
Sky Quarry (SKYQ) United States $0.018B 0.00
PicoCELA (PCLA) Japan $0.014B 0.00
Hong Kong Pharma Digital Technology Holdings (HKPD) $0.012B 0.00
OMS Energy Technologies (OMSE) $0.000B 0.00
Quartzsea Acquisition (QSEA) $0.000B 0.00
Galaxy Digital (GLXY) $0.000B 0.00
EToro Group (ETOR) $0.000B 0.00
Texas Ventures Acquisition III (TVA) $0.000B 0.00
Arrive AI (ARAI) $0.000B 0.00